Real-world Data From CROI: What’s New in HIV Care for Treatment-Experienced People

“Good enough” is no longer good enough when caring for treatment-experienced people with HIV. Tune in to find out what’s new in management of multidrug-resistant HIV and dig into the latest data from CROI 2026. Topics covered include:

Real-world experiences with LEN in the United States and Europe for management of multidrug-resistant HIV

• Pharmacokinetic profiles of combined LA CAB + LEN
• Ibalizumab for multidrug-resistant HIV
• Long-term 7-year outcomes for heavily treatment–experienced people living with HIV and 4-class drug resistance

To download the accompanying slides, please visit the program page: 
https://bit.ly/4pEenZC

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Onyema Ogbuagu, MD, FACP, FIDSA
Professor of Medicine and Pharmacology
Director, Yale Antivirals and Vaccines Research Program
Yale School of Medicine
New Haven, Connecticut

Charlotte-Paige Rolle, MD, MPH
Director of Research Operations
Orlando Immunology Center
Adjunct Assistant Professor of Global Health
Emory University Rollins School of Public Health
Atlanta, Georgia

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.